Literature DB >> 7282639

Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time.

J T Brandt, D A Triplett.   

Abstract

The CAP Hematology Survey of 1979-1980 included specimens with heparin levels between 0.0 and 0.8 U/ml. The results obtained with different reagent-instrument systems in common usage were analyzed. Sensitivity to heparin was dependent upon choice of reagent and did not appear to be influenced by choice of instrument. All systems displayed a loss of precision with increasing APTT which was independent of the choice of reagent. Compared to the photo-optical instruments, the BBL Fibrometer showed a greater loss of precision with longer APTT's. The results are discussed in terms of their effect on the laboratory's ability to adequately monitor heparin therapy.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7282639

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

Review 1.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Wide variability in the sensitivity of APTT reagents for monitoring of heparin dosage.

Authors:  S Kitchen; I Jennings; T A Woods; F E Preston
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

3.  Circadian changes in anticoagulant effect of heparin infused at a constant rate.

Authors:  H A Decousus; M Croze; F A Levi; J G Jaubert; B M Perpoint; J F De Bonadona; A Reinberg; P M Queneau
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-02

4.  Time-related effects of heparin sulfate on regional and systemic anticoagulation.

Authors:  C K Vincent; T W Wakefield; B Lindblad; J C Stanley; A W Fleming
Journal:  J Natl Med Assoc       Date:  1992-11       Impact factor: 1.798

Review 5.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

6.  Validation of high concentrated thrombin time assay for unfractionated heparin monitoring.

Authors:  Dollapak Apipongrat; Pornnapa Police; Rattapan Lamool; Punnee Butthep; Wittawat Chantkran
Journal:  J Clin Lab Anal       Date:  2022-09-13       Impact factor: 3.124

7.  Monitoring of anticoagulant therapy in heart disease: considerations for the current assays.

Authors:  Mohammadali Boroumand; Hamidreza Goodarzynejad
Journal:  J Tehran Heart Cent       Date:  2010-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.